We are live on ! Find out more
GCM

Glenview Capital Management Portfolio holdings

AUM $3.98B
1-Year Est. Return 20.52%
This Fund
S&P 500
This Quarter Est. Return
+10.06%
1 Year Est. Return
+20.52%
3 Year Est. Return
+68.18%
5 Year Est. Return
+87.14%
10 Year Est. Return
+400.35%
AUM
$3.19B
AUM Growth
-$441M
Cap. Flow
-$740M
Cap. Flow %
-23.22%
Top 10 Hldgs %
67.11%
Holding
51
New
7
Increased
9
Reduced
27
Closed
6

Top Buys

Rank Stock Value
1
MYGN icon
Myriad Genetics
MYGN
+$12M
2
MDT icon
Medtronic
MDT
+$11.4M
3
MSFT icon
Microsoft
MSFT
+$11.3M
4
AMGN icon
Amgen
AMGN
+$11.2M
5
DOC icon
Healthpeak Properties
DOC
+$11.2M

Top Sells

Rank Stock Value
1
NUAN
Nuance Communications, Inc.
NUAN
+$76.5M
2
HCA icon
HCA Healthcare
HCA
+$64.2M
3
PARA
Paramount Global Class B
PARA
+$62.1M
4
DVA icon
DaVita
DVA
+$50.7M
5
FMC icon
FMC
FMC
+$48.4M

Sector Composition

Rank Sector Weight
1 Healthcare 73.97%
2 Technology 9.8%
3 Consumer Discretionary 6%
4 Materials 4.64%
5 Communication Services 3.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
UNH icon
51
UnitedHealth
UNH
$370B
– –
-110,866
Closed -$32.7M
1 2
3

Similar funds

MAM
Martingale Asset Management Boston, Massachusetts $3.99B AUM 22.65% 1-Year Est. Return
USCWA
U.S. Capital Wealth Advisors Austin, Texas $3.98B AUM 22.36% 1-Year Est. Return
LWCA
Locust Wood Capital Advisers New York $3.95B AUM 33.1% 1-Year Est. Return
JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
AS
American Securities New York $3.93B AUM 52.22% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
BCP
BSN Capital Partners London, United Kingdom $3.93B AUM 13.09% 1-Year Est. Return
MIM
Meridiem Investment Management London, United Kingdom $3.92B AUM 1.64% 1-Year Est. Return

Glenview Capital Management's Q3 2020 Portfolio in Review

As of Q3 2020, Glenview Capital Management held 51 positions worth $3.19B, down 12% from $3.63B the previous quarter. Its ten largest holdings account for 67% of the portfolio.

Glenview Capital Management withdrew a net $740M in Q3 2020, closing 6 positions and reducing 27 holdings. Its most notable exit was UnitedHealth, an estimated $32.7M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 74% of assets, up from 70% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Glenview Capital Management opened a new position in Medtronic worth $11.8M.

  • Glenview Capital Management's largest Q3 2020 buy was Medtronic: 113,882 shares worth $11.8M.
  • Glenview Capital Management added most to Myriad Genetics in Q3 2020, an estimated $12M increase.
  • Glenview Capital Management's biggest Q3 2020 reduction was Nuance Communications, Inc., cutting an estimated $76.5M.
  • Glenview Capital Management fully exited UnitedHealth in Q3 2020, selling an estimated $32.7M.
  • Glenview Capital Management's ten largest holdings make up 67% of its $3.19B portfolio in Q3 2020.
  • Glenview Capital Management opened 7 new positions and closed 6 in Q3 2020.
  • Glenview Capital Management's portfolio value fell 12% quarter-over-quarter to $3.19B.

Based on Glenview Capital Management's 13F filing for Q3 2020, filed 16 Nov 2020.